|
Delayed
Toronto S.E.
17:32:15 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.125 CAD | +3.38% |
|
+4.43% | -14.42% |
| 09-24 | HLS Therapeutics Gets TSX Acceptance to Increase Normal Course Issuer Bid | MT |
| 08-12 | HLS Therapeutics Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.38% | +4.43% | +10.00% | -6.46% | -14.42% | -27.76% | -18.48% | -77.61% | - | 85.56M | |
| -0.35% | +2.49% | +1.98% | -1.65% | +9.77% | +54.60% | +119.14% | +410.55% | +1,369.76% | 1,056B | |
| -0.13% | -0.81% | +0.43% | +5.12% | +29.01% | +43.99% | +72.08% | +65.31% | +126.01% | 645B | |
| +0.15% | -0.62% | +2.74% | +4.69% | +15.30% | +13.78% | +77.70% | +144.22% | +317.69% | 465B | |
| -1.72% | -1.15% | -0.94% | +13.91% | +39.06% | +74.40% | +42.73% | +94.87% | +134.53% | 368B | |
| -0.06% | -3.88% | -1.05% | +4.90% | +6.37% | +34.32% | +40.74% | +2.09% | +44.85% | 335B | |
| -0.79% | +2.01% | -2.68% | -5.23% | +9.45% | +19.82% | +28.48% | +56.14% | +57.02% | 275B | |
| -1.19% | -1.21% | +2.66% | -12.91% | -10.95% | +9.82% | +12.15% | +37.08% | +145.40% | 255B | |
| -0.17% | +3.98% | -1.77% | +16.61% | +29.01% | +49.63% | +58.56% | +98.57% | +153.14% | 229B | |
| -0.77% | -0.83% | +2.58% | +18.81% | +22.30% | +35.23% | +102.58% | +114.90% | +89.72% | 188B | |
| +0.62% | +0.38% | -13.41% | -19.52% | -22.15% | -26.53% | -60.24% | -18.51% | +83.88% | 169B | |
| +0.26% | +2.08% | +1.07% | +19.46% | +15.52% | +12.89% | -15.25% | -33.12% | -15.07% | 164B | |
| -0.19% | +2.22% | -3.07% | +6.25% | +16.42% | +34.76% | +51.74% | +190.97% | +505.19% | 134B | |
| +0.25% | +2.86% | -5.85% | +9.16% | +16.61% | +39.47% | +8.73% | +6.30% | +16.65% | 128B | |
| -0.11% | -2.01% | -2.54% | +14.19% | +5.18% | +11.68% | +97.25% | +332.75% | +417.43% | 101B | |
| -1.29% | -2.86% | -2.11% | -7.52% | +0.41% | +16.35% | +23.45% | +4.42% | -10.80% | 98.21B | |
| +1.64% | -0.64% | -5.43% | -3.25% | -12.19% | -7.52% | -28.66% | -12.57% | +7.39% | 97.03B | |
| -7.51% | +3.46% | +34.25% | +169.04% | +538.89% | +629.42% | +82.37% | -51.04% | - | 81.23B | |
| +0.34% | -5.84% | -5.52% | +21.08% | -2.19% | +34.28% | -7.71% | +24.76% | +87.80% | 74.94B | |
| +0.51% | +3.87% | -0.65% | -5.96% | +12.64% | +26.18% | -10.61% | -26.41% | +43.99% | 67.69B | |
| Average | -0.34% | +0.22% | +0.53% | +12.04% | +35.20% | +53.94% | +33.84% | +68.18% | +198.59% | 246.51B | |
| Weighted average by Cap. | -0.42% | +0.28% | +0.21% | +6.15% | +22.37% | +45.05% | +59.13% | +140.73% | +407.77% |
- Stock Market
- Stocks
- HLS Stock
- Sector HLS Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
